Abstract
Chikungunya virus (CHIKV) and dengue virus (DENV) are two emerging arboviruses. CHIKV has recently re-emerged, causing massive epidemics that have moved from Africa throughout the Indian Ocean to India and Southeast Asia. In humans, it is responsible for an acute disease, characterized by a triad of fever, arthralgia and maculopapular rash. [1] Regarding the dengue fever, it affects more than 50 million people annually. [2] Increasing mortality and geographical expansion are the drastic changes noted in the recent epidemiology of the disease. No specific antiviral therapy is currently available, on the market, for these two diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
